Results 91 to 100 of about 41,794 (337)

Clinical and Procedural Effects of Transitioning to Contact Force Guided Ablation for Atrial Fibrillation. [PDF]

open access: yes, 2019
Background: A major innovation in atrial fibrillation (AF) ablation has been the introduction of contact force (CF) sensing catheters. Objective: To evaluate procedural and clinical effects of transitioning to CF-guided AF ablation.
Dikdan, Sean J., Frisch, Daniel R.
core   +1 more source

Bosentan for digital ulcers prevention does not worsen cardiopulmonary exercise test parameters in SSc patients with interstitial lung disease [PDF]

open access: yes, 2016
Bosentan for digital ulcers prevention does not worsen cardiopulmonary exercise test parameters in SSc patients with interstitial lung ...
Amoroso, Daria   +7 more
core   +1 more source

Autonomic Profile Changes after Pulsed‐Field versus Thermal Ablation in Patients with Atrial Fibrillation: A Systematic Review and Meta‐Analysis

open access: yesPacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Background Catheter ablation is an established therapy for atrial fibrillation (AF), with thermal ablation as a standard modality. Pulsed‐field ablation (PFA) is a nonthermal alternative that selectively ablates myocardium while sparing collateral tissue. Its comparative autonomic impact relative to thermal ablation remains unclear.
Ibrahim Antoun   +8 more
wiley   +1 more source

Amiodarone (cordarone) efficiency in atrial extrasystoles

open access: yesТерапевтический архив, 2004
Aim. To assess antiarrhythmic amiodarone efficacy of suppressing atrial extrasystoles resistant to other antiarrhythmic modalities. Material and methods.
D I Reingardene, A P Azaravichene
doaj  

Prevention of atrial tachyarrhythmia in post-operation period of pulmonary veins ostia catheter isolation in paroxysmal atrial fibrillation

open access: yesКардиоваскулярная терапия и профилактика, 2016
Aim. To study a complex approach in observation and medicationmonotherapy with assessment of its effectiveness and safety, with the following antiarrhythmic drugs (AAD): IC class propafenon, III class sotalol, IV class verapamil, — comparing to the ...
A. V. Tarasov   +3 more
doaj   +1 more source

Personalized Antiarrhythmic Therapy Using a Self-Managed Daily-ECG Device. [PDF]

open access: yesDiagnostics (Basel), 2023
Mattei E   +4 more
europepmc   +1 more source

A Cross-Sectional Study Comparing the Frequency of Drug Interactions After Adding Simeprevir- or Sofosbuvir-Containing Therapy to Medication Profiles of Hepatitis C Monoinfected Patients. [PDF]

open access: yes, 2015
INTRODUCTION:This study compares the expected occurrence of contraindicated drug-drug interactions (XDDIs) when simeprevir (SIM)- or sofosbuvir (SOF)-containing therapy is added to medication profiles of patients with hepatitis C (HCV) monoinfection to ...
Bliss, Steven   +6 more
core   +1 more source

Pulsed Field Ablation for Atrial Fibrillation in Patients With Obesity: Procedural and Clinical Outcomes

open access: yesPacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Background Procedural and clinical outcomes in patients with obesity undergoing catheter ablation for atrial fibrillation (AF) have been mixed. Clinical data in the context of pulsed field ablation (PFA) are currently limited in this patient cohort.
Francis J. Ha   +6 more
wiley   +1 more source

Preventing Sudden Death And The Use Of Prophylactic Implanted Defibrillators

open access: yesIndian Pacing and Electrophysiology Journal, 2003
Implanted defibrillators have become mainstream therapy for the prevention of sudden cardiac death from ventricular tachyarrhythmias. A decade of studies has confirmed the superiority of ICDs over antiarrhythmic drug therapy in prolonging the life of ...
Indranill Basu Ray
doaj  

Atrial fibrillation-associated electrical remodelling in human induced pluripotent stem cell-derived atrial cardiomyocytes: a novel pathway for antiarrhythmic therapy development. [PDF]

open access: yesCardiovasc Res, 2023
Seibertz F   +24 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy